logo

For the Inventor, By the Inventor

Malmö, Sweden

Rozana Sten

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Novo Nordisk A/s. Active years: 2018-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rozana Sten. Retrieved from https://idiyas.com/inventor/rozana-sten

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal2 out of 1,803 
 
Novo Nordisk A/s
 patents

Years Active: 2018-2020

Loading Chart...
2 patents (USPTO):Explore Patents
1. 10815299 - Anti-KIR antibodies, formulations, and uses thereof (2020-10-27),
2. 9879082 - Anti-KIR antibodies, formulations, and uses thereof (2018-01-30),

Title: Rozana Sten: Innovator in Anti-KIR Antibodies

Introduction

Rozana Sten is a prominent inventor based in Malmo, Sweden. She has made significant contributions to the field of immunology, particularly in the development of anti-KIR antibodies. With a total of 2 patents to her name, her work is paving the way for innovative therapeutic applications.

Latest Patents

Rozana's latest patents focus on anti-KIR antibodies, specifically a novel IgG4 isotype anti-KIR antibody. These patents detail formulations and methods for using these antibodies, which are crucial for natural killer (NK) cell activation. The patents also describe compositions, dosages, and administration regimens suitable for therapeutic applications in treating cancer. Additionally, kits comprising one or more anti-KIR antibodies with instructions for use are included in her innovative work.

Career Highlights

Rozana Sten is currently associated with Novo Nordisk A/S, a leading global healthcare company. Her role at Novo Nordisk allows her to further her research and development efforts in the field of immunotherapy. Her contributions are vital in advancing treatments that harness the body's immune system to combat cancer.

Collaborations

Throughout her career, Rozana has collaborated with notable colleagues, including Peter Andreas Nicolai Reumert Wagtmann and Ivan Svendsen. These collaborations have enriched her research and expanded the impact of her innovations in the scientific community.

Conclusion

Rozana Sten is a trailblazer in the field of anti-KIR antibodies, with her innovative patents and contributions to cancer treatment. Her work exemplifies the importance of research and collaboration in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…